The peptide was originally characterized by the Sikiric group at the University of Zagreb School of Medicine and has been investigated for over two decades in preclinical research models for its effects on tissue regeneration, angiogenesis, fibroblast migration, and cellular signaling across tendon, ligament, muscle, gastrointestinal, and vascular tissues
Endotoxin tested and produced under controlled laboratory conditions for research applications
Some patients report mild side effects such as nausea, headaches, fatigue, dizziness, or injection site irritation
The treatment of vitamin B12 deficiency depends on the severity of the condition
Instead, it is generally marketed as supporting the bodys natural fat-burning pathways
MICB+12 is ideal for those looking for a gentle metabolic boost, particularly during calorie deficits or exercise regimens